DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2025 with a number of business ...

The new Innovation Center for Neuroresilience (ICoN) aims to shift the focus from treatment to prevention of neurodegenerative diseases. The center brings together leading researchers in close ...

Forbes contributors publish independent expert analyses and insights. Gary Drenik is a writer covering AI, analytics and innovation. Innovation is increasingly intertwined with advancements in ...

Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced ...

LONDON--(BUSINESS WIRE)--AI has started to power all steps of research, development, and innovation (R&D&I), including those that require creativity, working alongside and augmenting humans, with its ...

WEST LAFAYETTE, Ind. — Chad Pittman has been named president and CEO of the Purdue Research Foundation (PRF), effective Feb. 1, 2025. Pittman succeeds Brian Edelman, who served as president since ...

Over the past decade, total U.S. expenditure on research and development (R&D) has nearly doubled. However, this growth has been unequal across performing sectors (public, private, academic, and ...

ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today released findings from two biotech sector surveys. The first survey focused on global biotech trends and is an update ...

In an age when antibiotic resistance poses a severe threat to global health, a new study sheds light on the often-overlooked hurdles of drug commercialization. Soaring costs associated with bringing ...

Measures to encourage spending on research and development in Budget 2026 have unlocked investment into the sector, according to a new KPMG report. The budget enacted an increase to the research and ...